Shanghai Miaozhifan Technology Co., Ltd. – Trademark Portfolio

Entity Type: 99

Shanghai Miaozhifan Technology Co., Ltd. holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 14 (Jewelry) — 2 filings in this category. Currently, 1 trademark is registered and 1 is pending. Notable registered marks include MOOLARM. The owner is based in Shanghai.

Lingang New Area, Pilot Free Trade Zone

Building C, No. 888, Huanhu Xi Er Road

Shanghai 200137 , CN

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

MOOLARM
MOOLARM
Registered 2026

Trademark Classifications

Shanghai Miaozhifan Technology Co., Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

14
Jewelry (2 filings)

Precious metals and their alloys; jewellery, precious stones; horological instruments

Frequently Asked Questions

How many trademarks does Shanghai Miaozhifan Technology Co., Ltd. have?

Shanghai Miaozhifan Technology Co., Ltd. has 2 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 pending.

What trademark classes does Shanghai Miaozhifan Technology Co., Ltd. file in?

Shanghai Miaozhifan Technology Co., Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 14 (Jewelry). Class 14 covers precious metals and their alloys; jewellery, precious stones; horological instruments.

What are Shanghai Miaozhifan Technology Co., Ltd.'s most well-known trademarks?

Shanghai Miaozhifan Technology Co., Ltd.'s registered trademark portfolio includes well-known marks such as MOOLARM. These are among 1 currently registered trademark in the portfolio.

What is Shanghai Miaozhifan Technology Co., Ltd.'s trademark registration success rate?

Shanghai Miaozhifan Technology Co., Ltd. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 1 application is pending review.